Given REV-ERBα gene-based correlation with alcohol use [23] and that agonist administration impairs cocaine reward sensitivity [29], it would seem to be an important target in the treatment of alcohol use disorders as well. This evidence concerns the gene NR1D1 and alcohol abuse.